AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • May 7th, 2021 • Inozyme Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Consulting Agreement (the “Agreement”) is made effective as of May 4, 2021 (the “Effective Date”), by and between Inozyme Pharma, Inc., a Delaware corporation, with its principal place of business being 321 Summer Street, Suite 400, Boston, MA 02210(the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability corporation, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”), which amends and restates that certain Consulting Agreement, dated January 21, 2016, by and among the Company and Danforth, as amended from time to time (the “Original Agreement”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
